HIV and HCV Intervention In Drug Treatment Settings - 1

Phase 3

Completed

• Conditions: Behavior Therapy

• Registration Number: NCT00102349
• Lead Sponsor: University of Colorado, Denver

Brief Summary

The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-11
• Study First Submitted: 2005-01-27
• Study First Submitted QC: 2005-01-27
• Study First Posted: 2005-01-28
• Primary Completion: 2006-02
• Study Completion: 2006-02
• Status Verified: 2016-10
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 706

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HIV/HCV injection risk behaviors

Trial Locations

Locations (8)

Island Grove RTC; 🇺🇸 Greeley, Colorado, United States

SSTAR of Rhode Island - North Kingstown; 🇺🇸 North Kingstown, Rhode Island, United States

Recovery Center King Co.-Kent Detox; 🇺🇸 Kent, Washington, United States

Willamette Family Treatment Services; 🇺🇸 Eugene, Oregon, United States

Denver Health & Hosp Authority; 🇺🇸 Denver, Colorado, United States

SSTAR (Stanley St. Treatment & Resources, Inc); 🇺🇸 Fall River, Massachusetts, United States

James Gilmore Jr. Treatment Center; 🇺🇸 Kalamazoo, Michigan, United States

Recovery Center King Co.-Seattle Detox; 🇺🇸 Seattle, Washington, United States